U. Björklund

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells

A. Hallberg, K. Wiman, V. Bykov, 2015, Cell Death and Disease.

The diurnal variation of serum hyaluronan in health and disease.

A. Engström‐Làurent, U. Björklund, A. Nyberg, 1988, Scandinavian journal of clinical and laboratory investigation.

PISARRO: A EUTROC phase Ib study of APR-246 in combination with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in platinum sensitive relapsed high grade serous ovarian cancer (HGSOC).

J. Brenton, H. Gabra, I. Vergote, 2016 .

The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders

Kutty Selva Nandakumar, R. Holmdahl, U. Björklund, 2008, Annals of the rheumatic diseases.

Rabeximod reduces arthritis severity in mice by decreasing activation of inflammatory cells

Kutty Selva Nandakumar, R. Holmdahl, U. Björklund, 2010, Annals of the rheumatic diseases.

Pentosan polysulphate (Elmiron): pharmacokinetics and effects on the urinary inhibition of crystal growth

U. Björklund, B. Fellström, B. Danielson, 1987 .

Anti‐inflammatory treatment of traumatic brain injury with Rabeximod reduces cerebral antigen presentation in mice

A. Kylberg, T. Ebendal, U. Björklund, 2015, Journal of neuroscience research.